$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Abstract

Biologically active recombinant human follicle stimulating hormone (rhFSH) was produced in Chinese hamster ovary cells and purified by a series of chromatographic steps. The chromatographic steps included anion-exchange chromatography (DEAE Sepharose F/F, Q Sepharose F/F), hydrophobic interaction chromatography (Source 15 PHE), and hydroxyapatite chromatography (Macro-Prep ceramic hydroxyapatite type I). A distinctive step of the purification process developed was the use of ZnCl$_2$ for the removal of non-glycosylated or lowly-glycosylated FSH and impurities through co-precipitation with Zn$^{2+}$. Purified rhFSH was identified and characterized by several physicochemical and biological methods such as gel electrophoresis, high-performance liquid chromatography, amino acid analysis, carbohydrate analysis, and biological activity. The overall yield of the purification was ~$30\%$. The rhFSH preparation obtained showed high purity (>$99\%$) and high in vivo potency (>16,000 IU/mg). Carbohydrate analysis suggested that the purified rhFSH contained approximately $40\%$ (w/w) carbohydrate with di­or tri-antennary structure on average, which is somewhat more heavily sialylated than commercially available rhFSH. In conclusion, the results of these analyses established an identity of the purified rhFSH with natural FSH from human pituitary glands, and furthermore, the purified rhFSH preparation showed higher in vivo potency and was slightly more heavily sialylated than commercially available rhFSH.

저자의 다른 논문

참고문헌 (32)

  1. Jennings, C. J.. K. Moreland, and C. M. Peterson. 1996. In vitro fertilization. Drugs 52: 313- 343 
  2. Jiang, N. S. and A. Albert. 1968. Purification of urinary follicle stimulating hormone by gel filtration in the presence of sodium dodecyl sulfate. J. Clin Endocrinol. 28: 1295- 1299 
  3. Loumaye, E., M. Dreano, A. Galazka, C. Howles, L. Ham, A. Munafo, and A. Eshkol. 1998. Recombinant follicle stimulating hormone: Development of the first biotechnology product for the treatment of infertility. Hum. Reprod. Update 4: 862-881 
  4. Olijve, W., W. de Boer, J. W. M. Mulders, and P. M. G. G. van Wezenbeek. 1996. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon${\circledR}$). Mol. Hum. Reprod. 2: 371- 382 
  5. Prevost, R. R. 1998. Recombinant follicle-stimulating hormone: New biotechnology for infertility. Pharmacotherapy 18: 1001-1010 
  6. Stanton, P. G., D. M. Robertson, P. G. Burgan, B. Schmauk-White, and M. T. W. Hearn. 1992. Isolation and physicochemical characterization of human follicle-stimulating hormone isoforms. Endocrinology 130: 2820- 2832 
  7. Loumaye, E., R. Campbell, and J. Salat-Baroux. 1995. Human follicle-stimulating hormone produced by recombinant DNA technology: A review for clinicians. Hum. Reprod. Update 1: 188- 199 
  8. Baenziger, J. U. and E. D. Green. 1988. Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of asparagines-linked oligosaccharides on lutropin, follitropin and thyrotropin. Biochim. Biophys. Acta 947: 287- 306 
  9. Finney, D. J. 1989. Statistical Method in Biological Assay. 3rd Ed. Charles Griffen & Company, London, U.K 
  10. Peckham, W. D. and A. F. Parlow. 1969. On the isolation of human pituitary follicle-stimulating hormone. Endocrinology 84: 953- 957 
  11. Chun, G.-T., J. B. Lee, S. U. Nam, S. W. Lee, Y. H. Jeong, E. Y. Choi, I. H. Kim, Y.-S. Jeong, and P-H. Kim. 2002. Screening of high-productivity cell lines and investigation of their physiology in Chinese hamster ovary (CHO) cell cultures for transforming growth $factor-\beta1$ production. J. Microbiol. Biotechnol. 12: 121- 129 
  12. De Leeuw, R., J. Mulders, G. Voortman. F. Rombout, J. Damm, and L. Kloosterboer. 1996. Structure-function relationship of recombinant follicle stimulating hormone (Puregon${\circledR}$). Mol. Hum. Reprod. 2: 361- 369 
  13. Kim, N. S., K. H. Chang, B. S. Chung, S. H. Kim, J. H. Kim, and G. M. Lee. 2003. Characterization of humanized antibody produced by apoptosis-resistant CHO cells under sodium butyrate-induced condition. J. Microbiol. Biotechnol. 13: 926- 936 
  14. Jackson, J. H. and P. J. Russell. 1984. Characteristics of the isoelectric focusing procedure: Importance of column size. pH, and protein-protein interactions. Anal. Biochem. 137: 41- 49 
  15. Speroff, L., R. H. Glass, and N. G. Kase. 1989. Clinical Gynecologic Endocrinology and Infertility, pp. 583- 609. 3rd Ed. Williams & Wikins, Baltimore, U.S.A 
  16. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680- 685 
  17. Cerpa-Poljak, A., L. A. Bishop, Y. J. Hort, C. K. H. Chin, R. de Kroon, S. M. Mahler, G. M. Smith, M. C. Stuart, and P. R. Schofield. 1993. Isoclectric charge of recombinant human follicle-stimulating hormone isoforrns determines receptor affinity and in vitro bioactivity. Endocrinology 132: 351-356 
  18. Howles, C. M. 1996. Genetic engineering of human FSH (Gonal-F${\circledR}$). Hum. Reprod. Update 2: 172- 191 
  19. Lee, S.-H., H.-S. Lee. M.-K. Lee, J.-H. Lee, J.-D. Kim, Y.-S. Park, S.-Y. Lee, and H.-Y. Lee. 2002. Enhancement of tissue type plasminogen activator (tPA) production from recombinant CHO cells by low electromagnetic fields. J. Microbiol. Biotechnol. 12: 457-462 
  20. Saxena, B. B. and P. Rathnam. 1967. Purification offolliclestimulating hormone from human pituitary glands. J. Biol. Chem. 17: 3769- 3775 
  21. Bagatti, G., C. Crisci, A. Datola, G. Gostoli, M. Mascia, P Polletta, G. Roncalli, and P Simoni. 2001. Characterisation and comparison of recombinant human follicle-stimulating hormones. J. Clin. Res. 4: 91- 104 
  22. Chapman, G. E., A. G. C. Renwick, and J. H. Livesey. 1981. The isolation of human pituitary hormones from frozen glands. J. Clin. Endocrinol. Metab. 53: 1008- 1013 
  23. Keene, J. L., M. M. Matzuk, T. Otani, B. C. J. M. Fauser, A. B. Galway, A. J. W. Hsueh, and I. Boime. 1989. Expression of biologically active human follitropin in Chinese hamster ovary cells. J. Biol. Chem. 264: 4769- 4775 
  24. Gharib, S. D., M. E. Wierman, M. A. Shupnik, and W. W. Chin. 1990. Molecular biology of the pituitary gonadotropins. Endocr. Rev. 11: 177- 199 
  25. Saxena, B. B. and P. Rathnam. 1976. Amino acid sequence of the b-subunit of follicle-stimulating hormone from human pituitary glands. J. Biol. Chem. 251: 993-1005 
  26. Tarr, G. E. 1986. Manual Edman sequencing system, pp. 155-194. In J. E. Shively (ed.), Methods of Protein Microcharacterization. Humana Press, Clifton, New Jersey, U.S.A 
  27. Chung, J. Y., H. K. Ahn, S. W. Lim, Y. H. Sung, Y. W. Koh. S. K. Park. and G. M. Lee. 2003. Development of recombinant Chinese hamster ovary cell lines producing human thrornbopoietin or its analog. J. Microbiol. Biotechnol. 13: 759-766 
  28. Johns, H. W. J., G. S. Johns, M. C. Andrew, A. Acosta, C. Bundren, J. Garcia, B. Sandow, and G. Wright. 1982. The program for in vitro fertilization at Norfolk. Fertil. Steril. 38: 14- 21 
  29. Rathnam, P. and B. B. Saxena. 1975. Primary amino acid sequence of follicle-stimulating hormone from human pituitary glands. J. Biol. Chem. 250: 6735- 6746 
  30. Chappel, S. C., A. Ulloa-Aguirre, and C. Coutifaris. 1983. Biosynthesis and secretion of follicle-stimulating hormone. Endocr. Rev. 4: 179- 211 
  31. Koh, S. B., K. S. Seo, S. C. Kim, B. O. Ahn, W. B. Kim, and S. H. Lee. 2002. Effect of recombinant human FSH on ovulation, pregnancy and in vitro fertilization in androgensterilized mice. Arch. Pharm. Res. 25: 357-363 
  32. Steelman, S. L. and F. M. Pohley. 1953. Assay of the folliclestimulating hormone based on the augmentation with human chorionic gonadotropin. Endocrinology 53: 604- 616 

이 논문을 인용한 문헌 (4)

  1. 2007. "" Journal of microbiology and biotechnology, 17(5): 712~720 
  2. 2007. "" Journal of microbiology and biotechnology, 17(6): 1036~1040 
  3. 2008. "" Journal of microbiology and biotechnology, 18(6): 1076~1080 
  4. 2008. "" Journal of microbiology and biotechnology, 18(1): 183~187 

원문보기

원문 PDF 다운로드

  • ScienceON :
  • KCI :

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일